Abstract
The effect of varying doses of cimetidine and omeprazole, on acute gastric mucosal lesions produced by topical aspirin (200 mg/kg; 1 ml/100 g) in 0.175 M HCl or topical sodium taurocholate (40 mM; 1 ml/100 g) in 0.175 M HCl was studied in the pylorus ligated rat. Preliminary studies revealed dose dependent inhibition of acid secretion with both cimetidine and omeprazole. Intraperitoneal cimetidine 50 mg/kg and 100 mg/kg given before topical acidified aspirin reduced mucosal lesions from a control score of 23.7 +/- 3.5 (mean +/- SEM) in which 83% of stomachs contained lesions, to 6.9 +/- 2.2 and 3.5 +/- 2.1 respectively (p less than 0.05), 36% and 27% of stomachs containing lesions. A dose of 250 mg/kg failed to reduce lesion score significantly (17.8 +/- 4.9) and 64% of stomachs contained lesions. Taurocholate-induced lesion score was reduced from a control value of 32.7 +/- 4.3 in which 97% of stomachs contained lesions to 10.8 +/- 3.3 and 15.5 +/- 3.8 by cimetidine 10 mg/kg and 25 mg/kg respectively (p less than 0.05), 62% and 68% of stomachs containing lesions. Cimetidine 50 mg/kg and 100 mg/kg failed to significantly reduce mucosal damage. Intraduodenal omeprazole (1.25 to 50 mumol/kg) given before topical acidified aspirin or taurocholate failed to reduce mucosal lesions, as did intragastric omeprazole 5 mumol/kg and 50 mumol/kg given before acidified aspirin. Cimetidine showed cytoprotective properties over a specific dose range beyond which the effect was lost despite continuing suppression of acid secretion. Omeprazole exhibited no cytoprotective activity.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bommelaer G., Guth P. H. Protection by histamine receptor antagonists and prostaglandin against gastric mucosal barrier disruption in the rat. Gastroenterology. 1979 Aug;77(2):303–308. [PubMed] [Google Scholar]
- Brodie D. A. The mechanism of gastric hyperacidity produced by pylorus ligation in the rat. Am J Dig Dis. 1966 Mar;11(3):231–241. doi: 10.1007/BF02233904. [DOI] [PubMed] [Google Scholar]
- Bunce K. T., Daly M. J., Humphray J. M., Stables R. H2-receptor antagonists protect against aspirin-induced gastric lesions in the rat. Agents Actions. 1981 Apr;11(1-2):167–170. doi: 10.1007/BF01991491. [DOI] [PubMed] [Google Scholar]
- Carmichael H. A., Nelson L. M., Russel R. I. Cimetidine and prostaglandin: evidence for different modes of action on the rat gastric mucosa. Gastroenterology. 1978 Jun;74(6):1229–1232. [PubMed] [Google Scholar]
- Fellenius E., Berglindh T., Sachs G., Olbe L., Elander B., Sjöstrand S. E., Wallmark B. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase. Nature. 1981 Mar 12;290(5802):159–161. doi: 10.1038/290159a0. [DOI] [PubMed] [Google Scholar]
- Guth P. H., Aures D., Paulsen G. Topical aspirin plus HCl gastric lesions in the rat. Cytoprotective effect of prostaglandin, cimetidine, and probanthine. Gastroenterology. 1979 Jan;76(1):88–93. [PubMed] [Google Scholar]
- Håkanson R., Hedenbro J., Liedberg G., Sundler F., Vallgren S. Mechanisms of gastric acid secretion after pylorus and oesophagus ligation in the rat. J Physiol. 1980 Aug;305:139–149. doi: 10.1113/jphysiol.1980.sp013355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kauffman G. L., Jr, Grossman M. I. Prostaglandin and cimetidine inhibit the formation of ulcers produced by parenteral salicylates. Gastroenterology. 1978 Dec;75(6):1099–1102. [PubMed] [Google Scholar]
- Kenyon G. S., Ansell I. F., Carter D. C. Cimetidine and the gastric mucosal barrier. Gut. 1977 Aug;18(8):631–635. doi: 10.1136/gut.18.8.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lind T., Cederberg C., Ekenved G., Haglund U., Olbe L. Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man. Gut. 1983 Apr;24(4):270–276. doi: 10.1136/gut.24.4.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Brien P. E., Carter D. C. Effect of gastric secretory inhibitors on the gastric mucosal barrier. Gut. 1975 Jun;16(6):437–442. doi: 10.1136/gut.16.6.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Brine P., Silen W. Influence of acid secretory state on the gastric mucosal tolerance to back diffusion of H+. Gastroenterology. 1976 Nov;71(5):760–765. [PubMed] [Google Scholar]
- Olbe L., Haglund U., Leth R., Lind T., Cederberg C., Ekenved G., Elander B., Fellenius E., Lundborg P., Wallmark B. Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans. Gastroenterology. 1982 Jul;83(1 Pt 2):193–198. [PubMed] [Google Scholar]
- Robert A., Nezamis J. E., Lancaster C., Hanchar A. J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology. 1979 Sep;77(3):433–443. [PubMed] [Google Scholar]
- Ross I. N., Turnberg L. A. Studies of the 'mucus-bicarbonate' barrier on rat fundic mucosa: the effects of luminal pH and a stable prostaglandin analogue. Gut. 1983 Nov;24(11):1030–1033. doi: 10.1136/gut.24.11.1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takeuchi K., Magee D., Critchlow J., Matthews J., Silen W. Studies of the pH gradient and thickness of frog gastric mucus gel. Gastroenterology. 1983 Feb;84(2):331–340. [PubMed] [Google Scholar]
- Walt R. P., Gomes M. D., Wood E. C., Logan L. H., Pounder R. E. Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J (Clin Res Ed) 1983 Jul 2;287(6384):12–14. doi: 10.1136/bmj.287.6384.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yamamoto O., Okada Y., Okabe S. Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats. Dig Dis Sci. 1984 May;29(5):394–401. doi: 10.1007/BF01296212. [DOI] [PubMed] [Google Scholar]
